Strategy to control spread of hiv drug resistance (SPREAD)

Informazioni relative al progetto

SPREAD

ID dell’accordo di sovvenzione: QLK2-CT-2001-01344

Progetto chiuso

Data di avvio 1 Gennaio 2002

Data di completamento 31 Dicembre 2005

Finanziato da

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Costo totale € 1 529 095,00

Contributo UE € 1 499 995,00

Coordinato da

UNIVERSITY HOSPITAL UTRECHT
Netherlands

Obiettivo

Human immunodeficiency viruses resistant to one or more HIV drugs are spreading throughout the world. If further spread of resistant HIV will not be controlled, a future situation may occur, in which no effective HIV drugs will be available for newly infected patients. The size of this problem in Europe is currently unknown, but it is estimated that approximately one fifth of all new infections are due to drug resistant viruses. No systematic information is collected and no strategy is available to prevent further spread of resistant viruses. Within the SPREAD-project clinicians, virologists and epidemiologists from 16 European countries will develop a strategy to control transmission of resistant HIV. They will collect data to reliably determine the incidence of transmission within the different risk groups and to identify risk factors enhancing the risk of transmission. Viruses from 4000 newly diagnosed individuals will be collected between 2001 and 2004 and characterised on mutational and phenotypic level by a network of quality controlled national reference laboratories. The data will be analysed using models and will be used to identify risk groups and predict future trends. Based on these analyses a European strategy will be developed and implemented in collaboration with public health authorities, the clinical community, pharmaceutical industry and patient...

Campo scientifico

• medical and health sciences › health sciences › public health
• natural sciences › biological sciences › microbiology › virology
• medical and health sciences › health sciences › infectious diseases › RNA viruses › HIV
• medical and health sciences › basic medicine › pharmacology and pharmacy › drug resistance

Programma(i)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Argomento(i)

• 1.1.1.-2. - Key action Control of Infectious Diseases

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

CSC - Cost-sharing contracts

Coordinatore

UNIVERSITY HOSPITAL UTRECHT

• Contributo UE: Nessun dato
• Indirizzo: Heidelberglaan 100 ; 3584 CX UTRECHT ; Paesi Bassi
• Costo totale: Nessun dato

Partecipanti (17)

CENTRE DE RECHERCHE PUBLIC DE LA SANTE

Lussemburgo

• Contributo UE: Nessun dato
• Indirizzo: Route Barble 4 ; 1210 LUXEMBOURG
• Costo totale: Nessun dato

FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA

Spagna

• Contributo UE: Nessun dato
• Indirizzo: Ctra. de Canyet s/n, Hospital Universitari Germans ; 08916 BADALONA
• Costo totale: Nessun dato

HELLENIC SCIENTIFIC SOCIETY FOR THE STUDY OF AIDS AND SEXUALLY TRANSMITTED DISEASES

Grecia

• Contributo UE: Nessun dato
• Indirizzo: Dragoumi Street 5 ; 16121 KAISARIANI / ATHENS
• Costo totale: Nessun dato

HOSPITAL DE EGAS MONIZ S.A

Portogallo

• Contributo UE: Nessun dato
• Indirizzo: Rua da Junqueira 126 ; 1349-019 LISBOA
• Costo totale: Nessun dato

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

Regno Unito

• Contributo UE: Nessun dato
• Indirizzo: ARC Building, Aspenlea Road 1 ; W6 8LH LONDON
• Costo totale: Nessun dato

KAROLINSKA INSTITUTE

Svezia

• Contributo UE: Nessun dato
• Indirizzo: Huddinge University Hospital ; 141 86 HUDDINGE
• Costo totale: Nessun dato

KATHOLIEKE UNIVERSITEIT LEUVEN

Belgio

• Contributo UE: Nessun dato
• Indirizzo: 10,Minderbroedersstraat 10 ; 3000 LOUVAIN / LEUVEN
• Costo totale: Nessun dato

NATIONAL PUBLIC HEALTH INSTITUTE

Finlandia

• Contributo UE: Nessun dato
• Indirizzo: Mannerheimintie 16 ; 00300 HELSINKI
• Costo totale: Nessun dato

NATIONAL UNIVERSITY OF IRELAND, DUBLIN

Irlanda

• Contributo UE: Nessun dato
• Indirizzo: Belfield ; 4 DUBLIN
• Costo totale: Nessun dato

NORWEGIAN INSTITUTE OF PUBLIC HEALTH

Norvegia

• Contributo UE: Nessun dato
• Indirizzo: Geitmyrsveien 75, Torshov ; 0403 OSLO
• Costo totale: Nessun dato

ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL OF UNIVERSITY COLLEGE LONDON

Regno Unito

• Contributo UE: Nessun dato
• Indirizzo: Rowland Hill Street ; HP16 0JS GREAT MISSENDEN/PRESTWOOD
• Costo totale: Nessun dato

STATENS SERUM INSTITUT

Danimarca

• Contributo UE: Nessun dato
• Indirizzo: Artillerivej 5 ; 2300 KOEPENHAGEN
• Costo totale: Nessun dato

THE UNIVERSITY OF MILANO

Italia

• Contributo UE: Nessun dato
• Indirizzo: L. Sacco Hospital, Via GB Grassi 74 ; 20157 MILANO
• Costo totale: Nessun dato

UNIVERSITY OF ERLANGEN-NUREMBERG

Germania

• Contributo UE: Nessun dato
• Indirizzo: 4,Schlossgarten 4 ; 91054 ERLANGEN
• Costo totale: Nessun dato

UNIVERSITY OF VIENNA

Austria

• Contributo UE: Nessun dato
• Indirizzo: Kinderspitalgasse 15 ; 1095 WIEN
• Costo totale: Nessun dato

VIROLOGY NETWORKS BV

Paesi Bassi

• Contributo UE: Nessun dato
• Indirizzo: Maliebaan 24-26 ; 3581 CP UTRECHT
• Costo totale: Nessun dato

WOJEWODZKI SZPITAL ZAKAZNY

Polonia

• Contributo UE: Nessun dato
• Indirizzo: Wolkska 37 ; 01 201 WARSZAWA
• Costo totale: Nessun dato